Tectonic Therapeutic, Inc.TECX

NasdaqHealthcareBiological Products, (No Diagnostic Substances)
Price (close)
$24.12
Market cap
$471.5M
P/E
—
Revenue (TTM)
—
Net income
-$85.8M
Dividend yield
—
1-year total return
64.0%
Net margin
—
Revenue growth
—
Debt / equity
—

What Tectonic Therapeutic, Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Net income-$119.7M-$119.1M-$105.9M-$42.8M-$58.0M-$74.2M
Free cash flow-$100.0M-$100.5M-$97.5M-$41.0M-$59.2M-$60.3M

More on TECX.

Figures from Tectonic Therapeutic, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.